0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R1,000 - R2,500 (1)
  • R5,000 - R10,000 (1)
  • -
Status
Brand

Showing 1 - 2 of 2 matches in All Departments

Antiviral Agents - Advances and Problems (Paperback, 2001 ed.): S. Ren, E.J. Lien, N.A Roberts, Q.-M. Wang, B.A. Heinz, K.A.... Antiviral Agents - Advances and Problems (Paperback, 2001 ed.)
S. Ren, E.J. Lien, N.A Roberts, Q.-M. Wang, B.A. Heinz, …
R1,704 Discovery Miles 17 040 Ships in 10 - 15 working days

In the treatment of infections caused by rapidly mutating viruses like human immunodeficiency virus (HIV), combination therapy with multiple drugs act ing by different mechanisms offers several advantages over monotherapy. It may provide: synergistic effect, possible reduction of dosages and side-effects, and reduction of the chance of drug resistance. In the past few years, hun dreds of HIV protease inhibitors have been synthesized and tested in order to overcome the limitations of reverse transcriptase inhibitors like zidovudine and others. In this review, emphasis is placed on the development of HIV pro tease inhibitors as antiviral agents against HIY, and structure-activity rela tionship analysis of saquinavir and related compounds. Limitations of some protease inhibitors and ways to overcome the shortcomings are presented. Among these many protease inhibitors five have been marketed during 1995-1999. They are saquinavir, ritonavir, indinavir, nelfinavir and ampre navir. Their different structural features, important physicochemical, phar macokinetic and clinical profiles are presented in a table form for easy com parison. It is hoped that in the future new drugs based on additional mech anisms can be developed for the treatment of AIDS. Contents 4 1 Introduction .................................................................... . HIV protease as a target for chemotherapy ................................... . 2 5 Design of protease inhibitors .................................................. . 3 5 Basis of rational design of HIV protease inhibitors ........................... . 3.1 5 New development of HIV protease inhibitors ................................ . 6 3.2 HIV protease inhibitors on the market ........................................ . 20 4 20 4.1 SAR of saquinavir and related compounds .................................... ."

Facility Management Reference Library CD, Second Edition (CD-ROM, 2nd New edition): Ed Bas, Heinz P. Bloch, Allan R Budris,... Facility Management Reference Library CD, Second Edition (CD-ROM, 2nd New edition)
Ed Bas, Heinz P. Bloch, Allan R Budris, Joseph F Gustin, Ken Heselton, …
R10,416 R8,914 Discovery Miles 89 140 Save R1,502 (14%) Ships in 12 - 17 working days

Today's facility manager is faced with a cross-section of job responsibilities and functions. Facility Management Reference Library CD, Second Edition is a comprehensive 11-volume reference library covering, from a facility manager's perspective, everything from water systems, facility assessment, air quality, lighting, boilers, and pumps to asset protection and terrorism. With more than 3,800 pages of text and graphics, this CD is an economical training, research, and reference resource. This powerful information tool allows you to print, create custom documents, and easily find the information that you need.

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
The Personal History Of David…
Dev Patel, Peter Capaldi, … DVD  (1)
R66 Discovery Miles 660
Loot
Nadine Gordimer Paperback  (2)
R398 R330 Discovery Miles 3 300
Loot
Nadine Gordimer Paperback  (2)
R398 R330 Discovery Miles 3 300
Poor Things
Emma Stone, Mark Ruffalo, … DVD R357 Discovery Miles 3 570
Vital BabyŽ NURTURE™ Ultra-Comfort…
R30 R23 Discovery Miles 230
Vital BabyŽ Nurture Microwave…
R167 R119 Discovery Miles 1 190
Casio LW-200-7AV Watch with 10-Year…
R999 R884 Discovery Miles 8 840
Microsoft Xbox Series X Console (1TB…
R16,499 Discovery Miles 164 990
Snappy Tritan Bottle (1.5L)(Green)
R229 R180 Discovery Miles 1 800
Gym Towel & Bag
R78 Discovery Miles 780

 

Partners